These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lipofuscin and macular degeneration. Wolf G Nutr Rev; 2003 Oct; 61(10):342-6. PubMed ID: 14604266 [TBL] [Abstract][Full Text] [Related]
3. Artificial light and early-life exposure in age-related macular degeneration and in cataractogenic phototoxicity. Simons K Arch Ophthalmol; 1993 Mar; 111(3):297-8. PubMed ID: 8447727 [No Abstract] [Full Text] [Related]
4. Light energy, cataract surgery, and progression of age-related macular degeneration. Smith BT; Belani S; Ho AC Curr Opin Ophthalmol; 2005 Jun; 16(3):166-9. PubMed ID: 15870573 [TBL] [Abstract][Full Text] [Related]
5. Vitamins A and E in RPE lipofuscin formation and implications for age-related macular degeneration. Eldred GE Prog Clin Biol Res; 1989; 314():113-29. PubMed ID: 2692024 [No Abstract] [Full Text] [Related]
6. Intraoperative light toxicity: a possible explanation for the association between cataract surgery and age-related macular degeneration. Libre PE Am J Ophthalmol; 2003 Nov; 136(5):961. PubMed ID: 14597070 [No Abstract] [Full Text] [Related]
7. Formation of a nonaoxirane from A2E, a lipofuscin fluorophore related to macular degeneration, and evidence of singlet oxygen involvement. Ben-Shabat S; Itagaki Y; Jockusch S; Sparrow JR; Turro NJ; Nakanishi K Angew Chem Int Ed Engl; 2002 Mar; 41(5):814-7. PubMed ID: 12491345 [No Abstract] [Full Text] [Related]
8. A2E, a byproduct of the visual cycle. Sparrow JR; Fishkin N; Zhou J; Cai B; Jang YP; Krane S; Itagaki Y; Nakanishi K Vision Res; 2003 Dec; 43(28):2983-90. PubMed ID: 14611934 [TBL] [Abstract][Full Text] [Related]
9. New molecular histopathologic insights into the pathogenesis of age-related macular degeneration. Handa JT Int Ophthalmol Clin; 2007; 47(1):15-50. PubMed ID: 17237672 [No Abstract] [Full Text] [Related]
10. Do blue light filters confer protection against age-related macular degeneration? Margrain TH; Boulton M; Marshall J; Sliney DH Prog Retin Eye Res; 2004 Sep; 23(5):523-31. PubMed ID: 15302349 [TBL] [Abstract][Full Text] [Related]
11. [What causes macular degeneration? 2 recently identified components can be the answer]. Ehinger B Lakartidningen; 1993 Jan; 90(1-2):56. PubMed ID: 8421406 [No Abstract] [Full Text] [Related]
12. Bisretinoids of RPE lipofuscin: trigger for complement activation in age-related macular degeneration. Sparrow JR Adv Exp Med Biol; 2010; 703():63-74. PubMed ID: 20711707 [TBL] [Abstract][Full Text] [Related]
13. Lipofuscin fluorophore inhibits lysosomal protein degradation and may cause early stages of macular degeneration. Eldred GE Gerontology; 1995; 41 Suppl 2():15-28. PubMed ID: 8821318 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Kinnunen K; Petrovski G; Moe MC; Berta A; Kaarniranta K Acta Ophthalmol; 2012 Jun; 90(4):299-309. PubMed ID: 22112056 [TBL] [Abstract][Full Text] [Related]
15. Light induces NLRP3 inflammasome activation in retinal pigment epithelial cells via lipofuscin-mediated photooxidative damage. Brandstetter C; Mohr LK; Latz E; Holz FG; Krohne TU J Mol Med (Berl); 2015 Aug; 93(8):905-16. PubMed ID: 25783493 [TBL] [Abstract][Full Text] [Related]
16. Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Kopitz J; Holz FG; Kaemmerer E; Schutt F Biochimie; 2004 Nov; 86(11):825-31. PubMed ID: 15589692 [TBL] [Abstract][Full Text] [Related]